{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Richard S. Schweiker, Secretary of Health and Human Services, announced today that Eli Lilly & Company had ''agreed to voluntarily suspend its sales and distribution of the anti-arthritic drug Oraflex.'' The Secretary's action late today followed a decision by the British authorities early this morning to temporarily suspend the sale of the drug, which is generically known as benoxaprofen. The drug is intended to reduce pain and inflammation caused by arthritis, but it has not been proved any more effective than aspirin, according to the Food and Drug Administration. The agency has been investigating the reports of 61 deaths in Britain and nine in the United States, as well as severe adverse reactions that have been associated with the drug.", "headline": {"main": "SALE OF ARTHRITIS DRUG SUSPENDED"}, "abstract": null, "print_page": "13", "word_count": 560, "_id": "4fd1258b8eb7c8105d5eb595", "snippet": "Richard S. Schweiker, Secretary of Health and Human Services, announced today that Eli Lilly & Company had ''agreed to voluntarily suspend its sales and distribution of the anti-arthritic drug Oraflex.''   The Secretary's action late today followed a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1982/08/05/us/sale-of-arthritis-drug-suspended.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "SALES"}, {"name": "subject", "value": "PAIN-RELIEVING DRUGS"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "CONTRACTS"}, {"name": "subject", "value": "RECALLS AND BANS OF PRODUCTS"}, {"name": "subject", "value": "DRUGS AND DRUG TRADE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "Special to the New York Times"}, "document_type": "article", "pub_date": "1982-08-05T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Living Desk", "lead_paragraph": "The Food and Drug Administration told a House subcommittee today that it was so swamped with paperwork that in one recent case it approved a painkiller for arthritis without knowing that it sometimes caused jaundice. This disclosure prompted the Subcommittee on Intergovernmental Relations to ask members of the F.D.A. at a hearing whether the agency had overlooked any other, more severe side effects of the drug, including fatal liver and kidney damage, that have been reported by European physicians in recent months. Agency spokesmen defended their review of the drug. They said that the overlooked reports on jaundice had been sent to the F.D.A. by the manufacturer, Eli Lilly & Company, to update clinical studies the company had referred to in making application for approval of the drug. They said their ignorance of the side effect did not reflect poorly on the agency's overall review.", "headline": {"main": "F.D.A. SAYS IT OVERLOOKED DRUG DATA"}, "abstract": null, "print_page": "1", "word_count": 1002, "_id": "4fd123888eb7c8105d5e7acb", "snippet": "The Food and Drug Administration told a House subcommittee today that it was so swamped with paperwork that in one recent case it approved a painkiller for arthritis without knowing that it sometimes caused jaundice.   This disclosure prompted the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1982/08/04/garden/fda-says-it-overlooked-drug-data.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "BUREAUCRATIC RED TAPE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "DRUGS AND DRUG TRADE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Michael", "lastname": "de COURCY"}], "original": "By MICHAEL deCOURCY HINDS, Special to the New York Times"}, "document_type": "article", "pub_date": "1982-08-04T00:00:00Z", "section_name": "Home and Garden; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "WASHINGTON SEVERE anxiety disorders that disrupt the lives of millions of adult Americans are attracting increased attention from Federal health officials. Some victims of these disorders suffer from irrational fears of a variety of objects and situations, such as insects, mice, or riding on elevators. Others experience sudden panic attacks marked by intense fear and feelings of impending doom - or a more persistent anxious mood that may last for months. And still others suffer stress following a psychologically traumatic event, such as rape, military combat, or disastrous accidents.", "headline": {"main": "ANXIETY: U.S. SEEKS IMPROVED INSIGHT INTO CAUSES"}, "abstract": null, "print_page": "1", "word_count": 977, "_id": "4fd1238c8eb7c8105d5e7df8", "snippet": "WASHINGTON SEVERE anxiety disorders that disrupt the lives of millions of adult Americans are attracting increased attention from Federal health officials.   Some victims of these disorders suffer from irrational fears of a variety of objects and...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1982/08/03/science/anxiety-us-seeks-improved-insight-into-causes.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By PHILIP M. BOFFEY"}, "document_type": "article", "pub_date": "1982-08-03T00:00:00Z", "section_name": "Science; Health"}], "meta": {"hits": 3, "offset": 0, "time": 33}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}